Developing an outcome measure with high luminance for optogenetics treatment of severe retinal degenerations and for gene therapy of cone diseases.
Investigative Ophthalmology and Visual Science.
Times cited: 6
Loss of the Metalloprotease ADAM9 Leads to Cone-Rod Dystrophy in Humans and Retinal Degeneration in Mice.
American Journal of Human Genetics.
Times cited: 52